Skip to contentB
Biofrontera Inc.
B
BFRIBiofrontera Inc. Q1 2024 · 10-Q
Revenue$7.91M$7.91M−9.4% vs Q1 2023 Net Income-$10.44M-$10.44MN/M vs Q1 2023 EPS Diluted-$2.88-$2.88N/M vs Q1 2023 Operating Income-$5,467,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
Free Cash Flowderived-$3,382,000N/M Margins · derivedOperating margin-69.1%−6.2 pt vs Q1 2023
Net margin-131.9%−46.3 pt vs Q1 2023
ended Mar 31, 2024 · filed May 15, 2024 · 45 d after period end